Pressure Bio, Constant Systems Ink Marketing, Sales Pact | GenomeWeb

NEW YORK (GenomeWeb News) – Pressure Biosciences said today that it has struck a co-marketing and distribution pact with UK-based Constant Systems that will enable the companies to offer each other's products in North America and Europe.

Under the agreement, Pressure Bio will receive non-exclusive rights to market, sell, and distribute CS's high-pressure cell disruption equipment and consumables in the US, Canada, and Mexico.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.

The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.

In PLOS this week: variants that affect COPD biomarkers, high genetic diversity of Cryptococcus gattii in Brazil, and more.